Student Academic Gains In Nursing Education: An Evaluation From Pharmacological and Ethical Point of View

Yıl 2019, Cilt: 2 Sayı: 1, 65 - 69, 25.04.2019

Evren Şavlı , Nülüfer Erbil

Öz

Adverse drug
reaction (ADR) reporting is a responsibility of nurses, ADR reporting in Turkey
is still below the average when compared to other countries. The aim of this
review is to raise an awareness of importance of pharmacovigilance
materiovigilance in curriculum and to underlie the role of nursing academics in higher education. In addition, it
is aimed to promote nurses effective ADR and medical device reaction reporting,
and also safe disposal of pharmaceuticals and personal care products and raise
awareness of second victim phenomenon. In this article the roles and
responsibilities of nursing educational practitioners and curricular
recommendations are based on the principles of pharmacology education.

Anahtar Kelimeler

Pharmacovigilance, materiovigilance, second victim, nursing

Hemşirelik Eğitiminde Öğrencinin Akademik Edinimleri: Farmakolojik ve Etik Bakış Açısından Bir Değerlendirme

Öz

Advers
ilaç reaksiyonlarının raporlanması hemşirelerin sorumluluklarındandır. Diğer
ülkelere kıyaslandığında, ülkemizdeki advers ilaç reaksiyonlarını raporlama
oranları hala ortalamanın altındadır. Bu derlemede amaç, ders programındaki
farmakovijilansın ve materyovijilansın önemi hakkında farkındalık oluşturmak ve
yükseköğretimdeki hemşirelik akademisyenlerinin rolünün altını çizmektir. Ayrıca
advers etki ve tıbbi cihaza bağlı olay raporlanmasını, kişisel bakım ürünleri
ve farmasötiklerin güvenli atılımını artırmak ve “second victim” fenomeni
hakkında farkındalık yaratmaktır. Bu makalede, hemşirelik eğitimcilerinin
rolleri ve sorumlulukları, ders programına yönelik öneriler farmakoloji
eğitiminin temellerine dayanmaktadır.

 

Anahtar Kelimeler

Pharmacovigilance, materiovigilance, second victim, nursing

Kaynakça

• REFERENCES Angamo MT, Chalmers L, Curtain CM, Bereznicki LRE. (2016) Adverse drug reaction related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug safety 39(9):847–57.
• Aydınkarahaliloğlu ND, Aykaç E, Atalan Ö, Demir N, Hayran M (2018) Spontaneous Reporting of Adverse Drug Reactions by Consumers in Comparison with Healthcare Professionals in Turkey from 2014 to 2016. Pharmaceutical Medicine 32:353–364
• Council of Higher Education electronic database (2015). http://www.osym.gov.tr/belge/1-19213/2012-2013-ogretim-yili-yuksek-ogretim-istatistikleri.html. (Erişim 15.06.2015). Guides of Student Selection and Placement Center (2015) http://dokuman.osym.gov.tr/pdfdokuman/2015/YGS/2015_OSYS_KILAVUZ.pdf. (Erişim 15.06.2015). Edrees H, Connors C, Paine L, Norvell M, Taylor H, Wu AW (2016). Implementing the RISE second victim support programme at the Johns Hopkins Hospital: a case study. BMJ Open. Sep 30;6(9):e011708.
• Frenk J, Chen L, Bhutta ZA (2010). Health professionals for a new century: Transforming education to strengthen health systems in an interdependent world. Lancet; 376: 1923–1958.
• Kohn L, Corrigan J, Donaldson M. (2000) To Err is Human: Building a Safer Health System. National Academy Press.
• Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA. (2008). HARM Study group. Frequency of and risk factors for preventable medication related hospital admissions in The Netherlands. JAMA Internal Medicine,168(17),1890–6.
• Institute of Medicine (US) Committee on the Work Environment for Nurses and Patient Safety; Page A, editor.Washington (DC): National Academies Press (US); 2004. Keeping Patients Safe: Transforming the Work Environment of Nurses.
• Makary MA, Daniel M. (2016) Medical error-the third leading cause of death in the US. BMJ, 353:i2139.
• National Nursing Core Training Program framework (2014) (HUÇEP-2014) Erişim tarihi: 14.03.2019,http://www.hemed.org.tr/index.php?option=com_content&task=view&id=547&Itemid=178
• Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley T, Farrar K, Park BK, Breckenridge AM. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ, 329(7456), 15–9.
• Scott SD, Hirschinger LE, Cox KR, McCoig M, Brandt J, Hall LW. (2009) The natural history of recovery for the healthcare provider ‘second victim’ after adverse patient events. BMJ Quality & Safety, 18(5), 325-330.
• T.C. Sağlık Bakanlığı Sağlık İstatistikleri Yıllığı (2017) Sayfa 217
• TMMDA (2002a). Relevant Turkish Legislation: Directive on Medical Devices published in Official Journal numbered 24694 and dated 13.03.2002
• TMMDA (2002b) Relevant Turkish Legislation : Directive on Active Implantable Medical Devices published in Official Journal numbered 24693 and dated 13.03.2002 TMMDA 2003.
• TMMDA (2003) Relevant Turkish Legislation: Directive on In Vitro Diagnostic Medical Devices published in Official Journal numbered 25259 and dated 14.10.2003. https://www.titck.gov.tr, Dosyalar/Erisim/TMMDABrochure.pdf Erişim Tarihi: 14.03.2019
• TMMDA (2014a) Turkish Drug and Medical Device Agency Regulation on safety of drugs.
• TMMDA (2014b) Turkish Drug and Medical Device Agency (2014) Good Pharmacovigilance Practices. Erişim tarihi 14.03.2019 https://www.titck.gov.tr/faaliyetalanlari/ilac/farmakovijilans
• World Health Organization (2009). Global standards for the initial education of professional nurses and midwives. Geneva: WHO.
• World Health Organization (2010).WHO consultation on the transformative scale-up ofmedical, nursing andmidwifery education. Second technical reference group meeting: Nursing and midwifery education experts 15–16 July 2010. Geneva: WHO.
• WHO, The Importance of Pharmacovigilance-Safety Monitoring of Medicinal Products (2002), p. 1-14.
• Wu AW (2000). Medical error: The second victim. The doctor who makes the mistake needs help too. British Medical Journal, 320 (7237), 726–727.